601
|
Yatsenko AN, Shroyer NF, Lewis RA, Lupski JR. An ABCA4 genomic deletion in patients with Stargardt disease. Hum Mutat 2003; 21:636-44. [PMID: 12754711 DOI: 10.1002/humu.10219] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Stargardt disease (STGD1) segregates with mutations in the ABCA4 (ABCR) locus. However, mutations of the ABCA4 coding region detected by sequencing account for only 66-80% of disease chromosomes. We hypothesized a potential contribution of otherwise undetected genomic rearrangements of the ABCA4 region. To investigate this hypothesis, we performed genomic Southern analysis on samples from 96 STGD families in which we had identified either one or no ABCA4 mutations by conventional methods. Among 192 chromosomes evaluated, we found one deletion (0.52%), IVS17-905_IVS18+35del, that spans 1,030 bp and eliminates exon 18 of ABCA4. By conceptual translation, this alteration creates an in-frame deletion of 30 amino acids, G885_H915del, and cosegregates with the disease in this family, implying a disease-associated allele. STGD subjects with this deletion were found to have a second mutant ABCA4 allele, 2588G>C. DNA sequence analysis of the deletion junction revealed consensus DNA topoisomerase I sites at both breakpoints that may predispose to nonhomologous recombination. Using deletion-specific PCR, we found the same allele in 2 of 308 STGD subjects (0.32%), in 1 of 96 age-related macular degeneration (AMD) subjects (0.52%), and in 2 of 480 (0.2%) individuals with no known eye diseases, but it was absent in a control group consisting of 96 individuals over age 60 and with normal eye examinations. In vitro biochemical studies of the cloned G885_H915del mutation revealed diminished expression, suggesting that partial deletion of the putative nucleotide-binding domain I leads to either misfolding or defective membrane interactions and eventually reduces the protein function in the retinopathy-affected subjects. Our experiments suggest that genomic alterations contribute to only a small fraction of retinopathy-associated alleles.
Collapse
Affiliation(s)
- Alexander N Yatsenko
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | | | |
Collapse
|
602
|
Abstract
Psychiatric conditions are to some degree under genetic influences. Despite the application of advanced genetic and molecular biological technologies, the genetic bases of the human behavioral traits and psychiatric diseases remains largely unresolved. Conventional genetic linkage approaches have not yielded definitive results, possibly because of the absence of objective diagnostic tests, the complex nature of human behavior or the incomplete penetrance of psychiatric traits. However, recent studies have revealed some genes of interest using multifaceted approaches to overcome these challenges. The approaches include using families in which specific behaviors segregate as a mendelian trait, utilization of endophenotypes as biological intermediate traits, identification of psychiatric disease phenotypes in genomic disorders, and the establishment of mouse models.
Collapse
Affiliation(s)
- Ken Inoue
- Departments of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Rm 604B, Houston, Texas 77030, USA.
| | | |
Collapse
|
603
|
O'Brien TP, Bult CJ, Cremer C, Grunze M, Knowles BB, Langowski J, McNally J, Pederson T, Politz JC, Pombo A, Schmahl G, Spatz JP, van Driel R. Genome function and nuclear architecture: from gene expression to nanoscience. Genome Res 2003; 13:1029-41. [PMID: 12743020 DOI: 10.1101/gr.946403] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Biophysical, chemical, and nanoscience approaches to the study of nuclear structure and activity have been developing recently and hold considerable promise. A selection of fundamental problems in genome organization and function are reviewed and discussed in the context of these new perspectives and approaches. Advancing these concepts will require coordinated networks of physicists, chemists, and materials scientists collaborating with cell, developmental, and genome biologists.
Collapse
|
604
|
Abstract
The slow Wallerian degeneration mouse, C57BL/Wld(S), carries a dominant mutation that delays Wallerian degeneration in the distal stump of an injured axon. A highly unusual mutation, an 85-kb tandem triplication in the Wld(S) mouse was identified. Since two duplication cases have been identified before, pulsed field gel electrophoresis (PFGE) can be used to look for the instability of triplication at the chromosomal level. One hundred and eighty chromosomes of Wld(S) from three divergent breeding colonies have been examined and all found to carry the triplication. Thus, the triplication mutation is stable during both mitosis and meiosis, and the previously observed duplication is likely to have been surviving alleles of the original mutation rather than a partial reversion. The triplication has now been shown to be the causative mutation, acting through an Ube4b/Nmnat chimeric gene, indicating the possibility of Wld(S) preventing axon degeneration in diverse pathologies and altering the symptoms. The fact that triplication is stable rules out instability as a source of phenotypic variation. Thus, this result is essential for accurate interpretation of studies the effect of Wld(S) on neurodegenerative phenotypes.
Collapse
Affiliation(s)
- Weiqian Mi
- Center for Molecular Medicine (ZMMK) and Institute for Genetics, University of Cologne, Zuelpicher Strasse 47, Germany.
| | | | | |
Collapse
|
605
|
Abstract
Large segmental duplications (SDs) constitute at least 3.6% of the human genome and have increased its size, complexity, and diversity. SDs can mediate ectopic sequence exchange resulting in gross chromosomal rearrangements that could contribute to speciation and disease. We have identified and evaluated a subset of human SDs that harbor an 88-member subfamily of olfactory receptor (OR)-like genes called the 7Es. At least 92% of these genes appear to be pseudogenes when compared to other OR genes. The 7E-containing SDs (7E SDs) have duplicated to at least 35 regions of the genome via intra- and interchromosomal duplication events. In contrast to many human SDs, the 7E SDs are not biased towards pericentromeric or subtelomeric regions. We find evidence for gene conversion among 7E genes and larger sequence exchange between 7E SDs, supporting the hypothesis that long, highly similar stretches of DNA facilitate ectopic interactions. The complex structure and history of the 7E SDs necessitates extension of the current model of large-scale DNA duplication. Despite their appearance as pseudogenes, some 7E genes exhibit a signature of purifying selection, and at least one 7E gene is expressed.
Collapse
Affiliation(s)
- Tera Newman
- Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
| | | |
Collapse
|
606
|
Walz K, Caratini-Rivera S, Bi W, Fonseca P, Mansouri DL, Lynch J, Vogel H, Noebels JL, Bradley A, Lupski JR. Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol 2003; 23:3646-55. [PMID: 12724422 PMCID: PMC154242 DOI: 10.1128/mcb.23.10.3646-3655.2003] [Citation(s) in RCA: 90] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Contiguous gene syndromes (CGS) are a group of disorders associated with chromosomal rearrangements of which the phenotype is thought to result from altered copy numbers of physically linked dosage-sensitive genes. Smith-Magenis syndrome (SMS) is a CGS associated with a deletion within band p11.2 of chromosome 17. Recently, patients harboring the predicted reciprocal duplication product [dup(17)(p11.2p11.2)] have been described as having a relatively mild phenotype. By chromosomal engineering, we created rearranged chromosomes carrying the deletion [Df(11)17] or duplication [Dp(11)17] of the syntenic region on mouse chromosome 11 that spans the genomic interval commonly deleted in SMS patients. Df(11)17/+ mice exhibit craniofacial abnormalities, seizures, marked obesity, and male-specific reduced fertility. Dp(11)17/+ animals are underweight and do not have seizures, craniofacial abnormalities, or reduced fertility. Examination of Df(11)17/Dp(11)17 animals suggests that most of the observed phenotypes result from gene dosage effects. Our murine models represent a powerful tool to analyze the consequences of gene dosage imbalance in this genomic interval and to investigate the molecular genetic bases of both SMS and dup(17)(p11.2p11.2).
Collapse
Affiliation(s)
- Katherina Walz
- Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
607
|
Slabaugh MB, Yu JK, Tang S, Heesacker A, Hu X, Lu G, Bidney D, Han F, Knapp SJ. Haplotyping and mapping a large cluster of downy mildew resistance gene candidates in sunflower using multilocus intron fragment length polymorphisms. PLANT BIOTECHNOLOGY JOURNAL 2003; 1:167-85. [PMID: 17156030 DOI: 10.1046/j.1467-7652.2003.00016.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Downy mildew (Plasmopara halstedii (Farl.) Berlese et de Toni) is a serious foliar pathogen of cultivated sunflower (Helianthus annuus L.). Genetic resistance is conditioned by several linked downy mildew resistance gene specificities in the HaRGC1 cluster of TIR-NBS-LRR resistance gene candidates (RGCs) on linkage group 8. The complexity and diversity of the HaRGC1 cluster was assessed by multilocus intron fragment length polymorphism (IFLP) genotyping using a single pair of primers flanking a hypervariable intron located between the TIR and NBS domains. Two to 23 bands were amplified per germplasm accession. The size of the included intron ranged from 89 to 858 nucleotides. Forty-eight unique markers were distinguished among 24 elite inbred lines, six partially isogenic inbred lines, nine open-pollinated populations, four Native American land races, and 20 wild H. annuus populations. Nine haplotypes (based on 24 RGCs) were identified among elite inbred lines and were correlated with known downy mildew resistance specificities. Sixteen out of 39 RGCs identified in wild H. annuus populations were not observed in elite germplasm. Five partially isogenic downy mildew resistant lines developed from wild H. annuus and H. praecox donors carried eight RGCs not found in other elite inbred lines. Twenty-four HaRGC1 loci were mapped to a 2-4 cM segment of linkage group 8. The multilocus IFLP marker and duplicated, hypervariable microsatellite markers tightly linked to the HaRGC1 cluster are powerful tools for distinguishing downy mildew resistance gene specificities and identifying and introgressing new downy mildew resistance gene specificities from wild sunflowers.
Collapse
Affiliation(s)
- Mary B Slabaugh
- Department of Crop and Soil Science, Oregon State University, Corvallis, OR 97331, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
608
|
Stankiewicz P, Shaw CJ, Dapper JD, Wakui K, Shaffer LG, Withers M, Elizondo L, Park SS, Lupski JR. Genome architecture catalyzes nonrecurrent chromosomal rearrangements. Am J Hum Genet 2003; 72:1101-16. [PMID: 12649807 PMCID: PMC1180264 DOI: 10.1086/374385] [Citation(s) in RCA: 140] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2002] [Accepted: 01/16/2003] [Indexed: 11/03/2022] Open
Abstract
To investigate the potential involvement of genome architecture in nonrecurrent chromosome rearrangements, we analyzed the breakpoints of eight translocations and 18 unusual-sized deletions involving human proximal 17p. Surprisingly, we found that many deletion breakpoints occurred in low-copy repeats (LCRs); 13 were associated with novel large LCR17p structures, and 2 mapped within an LCR sequence (middle SMS-REP) within the Smith-Magenis syndrome (SMS) common deletion. Three translocation breakpoints involving 17p11 were found to be located within the centromeric alpha-satellite sequence D17Z1, three within a pericentromeric segment, and one at the distal SMS-REP. Remarkably, our analysis reveals that LCRs constitute >23% of the analyzed genome sequence in proximal 17p--an experimental observation two- to fourfold higher than predictions based on virtual analysis of the genome. Our data demonstrate that higher-order genomic architecture involving LCRs plays a significant role not only in recurrent chromosome rearrangements but also in translocations and unusual-sized deletions involving 17p.
Collapse
Affiliation(s)
- Paweł Stankiewicz
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Christine J. Shaw
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Jason D. Dapper
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Keiko Wakui
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Lisa G. Shaffer
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Marjorie Withers
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Leah Elizondo
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Sung-Sup Park
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - James R. Lupski
- Departments of Molecular and Human Genetics and Pediatrics and Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, and Texas Children's Hospital, Houston
| |
Collapse
|
609
|
Tayebi N, Stubblefield BK, Park JK, Orvisky E, Walker JM, LaMarca ME, Sidransky E. Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease. Am J Hum Genet 2003; 72:519-34. [PMID: 12587096 PMCID: PMC1180228 DOI: 10.1086/367850] [Citation(s) in RCA: 91] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2002] [Accepted: 11/26/2002] [Indexed: 11/03/2022] Open
Abstract
Gaucher disease results from an autosomal recessive deficiency of the lysosomal enzyme glucocerebrosidase. The glucocerebrosidase gene is located in a gene-rich region of 1q21 that contains six genes and two pseudogenes within 75 kb. The presence of contiguous, highly homologous pseudogenes for both glucocerebrosidase and metaxin at the locus increases the likelihood of DNA rearrangements in this region. These recombinations can complicate genotyping in patients with Gaucher disease and contribute to the difficulty in interpreting genotype-phenotype correlations in this disorder. In the present study, DNA samples from 240 patients with Gaucher disease were examined using several complementary approaches to identify and characterize recombinant alleles, including direct sequencing, long-template polymerase chain reaction, polymorphic microsatellite repeats, and Southern blots. Among the 480 alleles studied, 59 recombinant alleles were identified, including 34 gene conversions, 18 fusions, and 7 downstream duplications. Twenty-two percent of the patients evaluated had at least one recombinant allele. Twenty-six recombinant alleles were found among 310 alleles from patients with type 1 disease, 18 among 74 alleles from patients with type 2 disease, and 15 among 96 alleles from patients with type 3 disease. Several patients carried two recombinations or mutations on the same allele. Generally, alleles resulting from nonreciprocal recombination (gene conversion) could be distinguished from those arising by reciprocal recombination (crossover and exchange), and the length of the converted sequence was determined. Homozygosity for a recombinant allele was associated with early lethality. Ten different sites of crossover and a shared pentamer motif sequence (CACCA) that could be a hotspot for recombination were identified. These findings contribute to a better understanding of genotype-phenotype relationships in Gaucher disease and may provide insights into the mechanisms of DNA rearrangement in other disorders.
Collapse
Affiliation(s)
- Nahid Tayebi
- Clinical Neuroscience Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
| | | | | | | | | | | | | |
Collapse
|
610
|
Nicholls RD. 2002 Curt Stern Award address. Introductory speech for James R. Lupski. Am J Hum Genet 2003; 72:244-5. [PMID: 12635650 PMCID: PMC379219 DOI: 10.1086/346216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Robert D Nicholls
- Center for Neurobiology and Behavior, Departments of Psychiatry and Genetics, University of Pennsylvania, Philadelphia, PA 19104-6140, USA .
| |
Collapse
|
611
|
Lupski JR. 2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture. Am J Hum Genet 2003; 72:246-52. [PMID: 12596790 PMCID: PMC379220 DOI: 10.1086/346217] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- James R Lupski
- Department of Molecular and Human Genetics, Baylor College of Medicine and Texas Children's Hospital, Houston, 77030, USA.
| |
Collapse
|
612
|
Guy J, Hearn T, Crosier M, Mudge J, Viggiano L, Koczan D, Thiesen HJ, Bailey JA, Horvath JE, Eichler EE, Earthrowl ME, Deloukas P, French L, Rogers J, Bentley D, Jackson MS. Genomic sequence and transcriptional profile of the boundary between pericentromeric satellites and genes on human chromosome arm 10p. Genome Res 2003; 13:159-72. [PMID: 12566394 PMCID: PMC420363 DOI: 10.1101/gr.644503] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2002] [Accepted: 11/04/2002] [Indexed: 11/24/2022]
Abstract
Contiguous finished sequence from highly duplicated pericentromeric regions of human chromosomes is needed if we are to understand the role of pericentromeric instability in disease, and in gene and karyotype evolution. Here, we have constructed a BAC contig spanning the transition from pericentromeric satellites to genes on the short arm of human chromosome 10, and used this to generate 1.4 Mb of finished genomic sequence. Combining RT-PCR, in silico gene prediction, and paralogy analysis, we can identify two domains within the sequence. The proximal 600 kb consists of satellite-rich pericentromerically duplicated DNA which is transcript poor, containing only three unspliced transcripts. In contrast, the distal 850 kb contains four known genes (ZNF248, ZNF25, ZNF33A, and ZNF37A) and up to 32 additional transcripts of unknown function. This distal region also contains seven out of the eight intrachromosomal duplications within the sequence, including the p arm copy of the approximately 250-kb duplication which gave rise to ZNF33A and ZNF33B. By sequencing orthologs of the duplicated ZNF33 genes we have established that ZNF33A has diverged significantly at residues critical for DNA binding but ZNF33B has not, indicating that ZNF33B has remained constrained by selection for ancestral gene function. These results provide further evidence of gene formation within intrachromosomal duplications, but indicate that recent interchromosomal duplications at this centromere have involved transcriptionally inert, satellite rich DNA, which is likely to be heterochromatic. This suggests that any novel gene structures formed by these interchromosomal events would require relocation to a more open chromatin environment to be expressed.
Collapse
Affiliation(s)
- Jane Guy
- The Institute of Human Genetics, The International Centre for Life, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 3BZ, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
613
|
Shaw CJ, Stankiewicz P, Christodoulou J, Smith E, Jones K, Lupski JR. A girl with duplication 17p10-p12 associated with a dicentric chromosome. ACTA ACUST UNITED AC 2003; 124A:173-8. [PMID: 14699617 DOI: 10.1002/ajmg.a.20355] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
We report a 7 1/2-year-old girl with an approximately 9.5 Mb duplication of proximal 17p. Her clinical features include moderately severe developmental delay, absence of speech, talipes, congenital dislocation of the hips, premature adrenarche, dysmorphic facial features, deep palmar creases, and signs and symptoms of peripheral neuropathy consistent with Charcot-Marie-Tooth disease type 1A (CMT1A). Chromosome analysis revealed a partially duplicated 17p with two centromeres on the derivative chromosome. Fluorescence in situ hybridization (FISH) analysis demonstrated the tandemly duplicated segment spans 17p10-p12, including the entire Smith-Magenis syndrome (SMS) critical region and a portion of the CMT1A critical region. One breakpoint mapped within the centromere and the second breakpoint mapped within the CMT1A critical region, distal to the PMP22 gene. Microsatellite polymorphism studies showed that the duplicated chromosome is of maternal origin. We compare the clinical features of our patient to those of individuals with partial trisomy of proximal 17p to further delineate the genotype-phenotype correlation associated with segmental duplication of this chromosomal region.
Collapse
Affiliation(s)
- Christine J Shaw
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
| | | | | | | | | | | |
Collapse
|
614
|
Cheung J, Estivill X, Khaja R, MacDonald JR, Lau K, Tsui LC, Scherer SW. Genome-wide detection of segmental duplications and potential assembly errors in the human genome sequence. Genome Biol 2003; 4:R25. [PMID: 12702206 PMCID: PMC154576 DOI: 10.1186/gb-2003-4-4-r25] [Citation(s) in RCA: 173] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2002] [Revised: 01/22/2003] [Accepted: 02/21/2003] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND Previous studies have suggested that recent segmental duplications, which are often involved in chromosome rearrangements underlying genomic disease, account for some 5% of the human genome. We have developed rapid computational heuristics based on BLAST analysis to detect segmental duplications, as well as regions containing potential sequence misassignments in the human genome assemblies. RESULTS Our analysis of the June 2002 public human genome assembly revealed that 107.4 of 3,043.1 megabases (Mb) (3.53%) of sequence contained segmental duplications, each with size equal or more than 5 kb and 90% identity. We have also detected that 38.9 Mb (1.28%) of sequence within this assembly is likely to be involved in sequence misassignment errors. Furthermore, we have identified a significant subset (199,965 of 2,327,473 or 8.6%) of single-nucleotide polymorphisms (SNPs) in the public databases that are not true SNPs but are potential paralogous sequence variants. CONCLUSION Using two distinct computational approaches, we have identified most of the sequences in the human genome that have undergone recent segmental duplications. Near-identical segmental duplications present a major challenge to the completion of the human genome sequence. Potential sequence misassignments detected in this study would require additional efforts to resolve.
Collapse
Affiliation(s)
- Joseph Cheung
- Program in Genetics and Genomic Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada
| | - Xavier Estivill
- Program in Genetics and Genomic Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada
- Genes and Disease Program, Genomic Regulation Center, and Facultat Ciencies de la Salut i de la Vida, Universitat Pompeu Fabra, E-08003 Barcelona, Catalonia, Spain
| | - Razi Khaja
- Program in Genetics and Genomic Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada
| | - Jeffrey R MacDonald
- Program in Genetics and Genomic Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada
| | - Ken Lau
- Program in Genetics and Genomic Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada
| | - Lap-Chee Tsui
- Program in Genetics and Genomic Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada
- Department of Molecular and Medical Genetics, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada
- Current address: The University of Hong Kong, Pokfulam Road, Hong Kong
| | - Stephen W Scherer
- Program in Genetics and Genomic Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada
- Department of Molecular and Medical Genetics, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada
| |
Collapse
|
615
|
Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TRP, Rahman N. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 2003; 72:132-43. [PMID: 12464997 PMCID: PMC378618 DOI: 10.1086/345647] [Citation(s) in RCA: 195] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2002] [Accepted: 10/14/2002] [Indexed: 12/28/2022] Open
Abstract
Sotos syndrome is a childhood overgrowth syndrome characterized by a distinctive facial appearance, height and head circumference >97th percentile, advanced bone age, and developmental delay. Weaver syndrome is characterized by the same criteria but has its own distinctive facial gestalt. Recently, a 2.2-Mb chromosome 5q35 microdeletion, encompassing NSD1, was reported as the major cause of Sotos syndrome, with intragenic NSD1 mutations identified in a minority of cases. We evaluated 75 patients with childhood overgrowth, for intragenic mutations and large deletions of NSD1. The series was phenotypically scored into four groups, prior to the molecular analyses: the phenotype in group 1 (n=37) was typical of Sotos syndrome; the phenotype in group 2 (n=13) was Sotos-like but with some atypical features; patients in group 3 (n=7) had Weaver syndrome, and patients in group 4 (n=18) had an overgrowth condition that was neither Sotos nor Weaver syndrome. We detected three deletions and 32 mutations (13 frameshift, 8 nonsense, 2 splice-site, and 9 missense) that are likely to impair NSD1 functions. The truncating mutations were spread throughout NSD1, but there was evidence of clustering of missense mutations in highly conserved functional domains between exons 13 and 23. There was a strong correlation between presence of an NSD1 alteration and clinical phenotype, in that 28 of 37 (76%) patients in group 1 had NSD1 mutations or deletions, whereas none of the patients in group 4 had abnormalities of NSD1. Three patients with Weaver syndrome had NSD1 mutations, all between amino acids 2142 and 2184. We conclude that intragenic mutations of NSD1 are the major cause of Sotos syndrome and account for some Weaver syndrome cases but rarely occur in other childhood overgrowth phenotypes.
Collapse
Affiliation(s)
- Jenny Douglas
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Sandra Hanks
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - I. Karen Temple
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Sally Davies
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Alexandra Murray
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Meena Upadhyaya
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Susan Tomkins
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Helen E. Hughes
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Trevor R. P. Cole
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| | - Nazneen Rahman
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Department of Human Genetics, Southampton University Hospital, Southampton, United Kingdom; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom; Department of Clinical Genetics, St. James University Hospital, Leeds, United Kingdom; and Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom
| |
Collapse
|
616
|
Thomas JW, Schueler MG, Summers TJ, Blakesley RW, McDowell JC, Thomas PJ, Idol JR, Maduro VVB, Lee-Lin SQ, Touchman JW, Bouffard GG, Beckstrom-Sternberg SM, Green ED. Pericentromeric duplications in the laboratory mouse. Genome Res 2003; 13:55-63. [PMID: 12529306 PMCID: PMC430956 DOI: 10.1101/gr.791403] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Duplications have long been postulated to be an important mechanism by which genomes evolve. Interspecies genomic comparisons are one method by which the origin and molecular mechanism of duplications can be inferred. By comparative mapping in human, mouse, and rat, we previously found evidence for a recent chromosome-fission event that occurred in the mouse lineage. Cytogenetic mapping revealed that the genomic segments flanking the fission site appeared to be duplicated, with copies residing near the centromere of multiple mouse chromosomes. Here we report the mapping and sequencing of the regions of mouse chromosomes 5 and 6 involved in this chromosome-fission event as well as the results of comparative sequence analysis with the orthologous human and rat genomic regions. Our data indicate that the duplications associated with mouse chromosomes 5 and 6 are recent and that the resulting duplicated segments share significant sequence similarity with a series of regions near the centromeres of the mouse chromosomes previously identified by cytogenetic mapping. We also identified pericentromeric duplicated segments shared between mouse chromosomes 5 and 1. Finally, novel mouse satellite sequences as well as putative chimeric transcripts were found to be associated with the duplicated segments. Together, these findings demonstrate that pericentromeric duplications are not restricted to primates and may be a common mechanism for genome evolution in mammals.
Collapse
Affiliation(s)
- James W Thomas
- Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
617
|
Birth of ‘human-specific’ genes during primate evolution. CONTEMPORARY ISSUES IN GENETICS AND EVOLUTION 2003. [DOI: 10.1007/978-94-010-0229-5_9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
618
|
Abstract
Genomic rearrangements play a major role in the pathogenesis of human genetic diseases. Nonallelic homologous recombination (NAHR) between low-copy repeats (LCRs) that flank unique genomic segments results in changes of genome organization and can cause a loss or gain of genomic segments. These LCRs appear to have arisen recently during primate speciation via paralogous segmental duplication, thus making the human species particularly susceptible to genomic rearrangements. Genomic disorders are defined as a group of diseases that result from genomic rearrangements, mostly mediated by NAHR. Molecular investigations of genomic disorders have revealed genome architectural features associated with susceptibility to rearrangements and the recombination mechanisms responsible for such rearrangements. The human genome sequence project reveals that LCRs may account for 5% of the genome, suggesting that many novel genomic disorders might still remain to be recognized.
Collapse
Affiliation(s)
- Ken Inoue
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
| | | |
Collapse
|
619
|
Bandyopadhyay R, Heller A, Knox-DuBois C, McCaskill C, Berend SA, Page SL, Shaffer LG. Parental origin and timing of de novo Robertsonian translocation formation. Am J Hum Genet 2002; 71:1456-62. [PMID: 12424707 PMCID: PMC378592 DOI: 10.1086/344662] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2002] [Accepted: 09/05/2002] [Indexed: 11/03/2022] Open
Abstract
Robertsonian translocations (ROBs) are the most common chromosomal rearrangements in humans. ROBs are whole-arm rearrangements between the acrocentric chromosomes 13-15, 21, and 22. ROBs can be classified into two groups depending on their frequency of occurrence, common (rob(13q14q) and rob(14q21q)), and rare (all remaining possible nonhomologous combinations). Herein, we have studied 29 case subjects of common and rare de novo ROBs to determine their parental origins and timing of formation. We compared these case subjects to 35 published case subjects of common ROBs and found that most common ROBs apparently have the same breakpoints and arise mainly during oogenesis (50/54). These probably form through a common mechanism and have been termed "class 1." Collectively, rare ROBs also occur mostly during oogenesis (7/10) but probably arise through a more "random" mechanism or a variety of mechanisms and have been termed "class 2." Thus, we demonstrate that although both classes of ROBs occur predominantly during meiosis, the common, class 1 ROBs occur primarily during oogenesis and likely form through a mechanism distinct from that forming class 2 ROBs.
Collapse
Affiliation(s)
- Ruma Bandyopadhyay
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; Institute for Human Genetics and Anthropology, Jena, Germany; Genzyme Genetics, Santa Fe; and Stowers Institute for Medical Research, Kansas City, MO
| | - Anita Heller
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; Institute for Human Genetics and Anthropology, Jena, Germany; Genzyme Genetics, Santa Fe; and Stowers Institute for Medical Research, Kansas City, MO
| | - Cami Knox-DuBois
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; Institute for Human Genetics and Anthropology, Jena, Germany; Genzyme Genetics, Santa Fe; and Stowers Institute for Medical Research, Kansas City, MO
| | - Christopher McCaskill
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; Institute for Human Genetics and Anthropology, Jena, Germany; Genzyme Genetics, Santa Fe; and Stowers Institute for Medical Research, Kansas City, MO
| | - Sue Ann Berend
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; Institute for Human Genetics and Anthropology, Jena, Germany; Genzyme Genetics, Santa Fe; and Stowers Institute for Medical Research, Kansas City, MO
| | - Scott L. Page
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; Institute for Human Genetics and Anthropology, Jena, Germany; Genzyme Genetics, Santa Fe; and Stowers Institute for Medical Research, Kansas City, MO
| | - Lisa G. Shaffer
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; Institute for Human Genetics and Anthropology, Jena, Germany; Genzyme Genetics, Santa Fe; and Stowers Institute for Medical Research, Kansas City, MO
| |
Collapse
|
620
|
Collier DA. FISH, flexible joints and panic: are anxiety disorders really expressions of instability in the human genome? Br J Psychiatry 2002; 181:457-9. [PMID: 12456511 DOI: 10.1192/bjp.181.6.457] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
621
|
Shaw CJ, Bi W, Lupski JR. Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2. Am J Hum Genet 2002; 71:1072-81. [PMID: 12375235 PMCID: PMC420000 DOI: 10.1086/344346] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2002] [Accepted: 08/14/2002] [Indexed: 12/11/2022] Open
Abstract
A number of common contiguous gene syndromes have been shown to result from nonallelic homologous recombination (NAHR) within region-specific low-copy repeats (LCRs). The reciprocal duplications are predicted to occur at the same frequency; however, probably because of ascertainment bias and milder phenotypes, reciprocal events have been identified in only a few cases to date. We previously described seven patients with dup(17)(p11.2p11.2), the reciprocal of the Smith-Magenis syndrome (SMS) deletion, del(17)(p11.2p11.2). In >90% of patients with SMS, identical approximately 3.7-Mb deletions in 17p11.2 have been identified. These deletions are flanked by large (approximately 200 kb), highly homologous, directly oriented LCRs (i.e., proximal and distal SMS repeats [SMS-REPs]). The third (middle) SMS-REP is inverted with respect to them and maps inside the commonly deleted genomic region. To investigate the parental origin and to determine whether the common deletion and duplication arise by unequal crossovers mediated through NAHR between the proximal and distal SMS-REPs, we analyzed the haplotypes of 14 families with SMS and six families with dup(17)(p11.2p11.2), using microsatellite markers directly flanking the SMS common deletion breakpoints. Our data indicate that reciprocal deletion and duplication of 17p11.2 result from unequal meiotic crossovers. These rearrangements occur via both interchromosomal and intrachromosomal exchange events between the proximal and distal SMS-REPs, and there appears to be no parental-origin bias associated with common SMS deletions and the reciprocal duplications.
Collapse
Affiliation(s)
- Christine J. Shaw
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - Weimin Bi
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston
| | - James R. Lupski
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston
| |
Collapse
|
622
|
Lebbar A, Viot G, Szpiro-Tapia S, Baverel F, Rabineau D, Dupont JM. Pregnancy outcome following prenatal diagnosis of an isodicentric X chromosome: first case report. Prenat Diagn 2002; 22:973-5. [PMID: 12424758 DOI: 10.1002/pd.444] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
An isodicentric X chromosome, idic (X)(q27) was found in a female fetus during cytogenetic studies performed on amniotic cells due to advanced maternal age. No mosaicism was observed. Although segmental inversion duplications have been described for several other chromosomes, isodicentric chromosomes are reported only for gonosomes. Genetic counselling was based on ultrasound findings, cytogenetic replication studies and published cases of X chromosomes duplications ascertained pre- and postnatally. The pregnancy resulted in the birth of a healthy female infant.
Collapse
Affiliation(s)
- A Lebbar
- Service d'Histologie-Embryologie-Cytogénétique, Hôpital Cochin-Port Royal, AP/HP-Université Paris 5, Paris, France.
| | | | | | | | | | | |
Collapse
|
623
|
Fan Y, Newman T, Linardopoulou E, Trask BJ. Gene content and function of the ancestral chromosome fusion site in human chromosome 2q13-2q14.1 and paralogous regions. Genome Res 2002; 12:1663-72. [PMID: 12421752 PMCID: PMC187549 DOI: 10.1101/gr.338402] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2002] [Accepted: 09/10/2002] [Indexed: 01/19/2023]
Abstract
Various portions of the region surrounding the site where two ancestral chromosomes fused to form human chromosome 2 are duplicated elsewhere in the human genome, primarily in subtelomeric and pericentromeric locations. At least 24 potentially functional genes and 16 pseudogenes reside in the 614-kb of sequence surrounding the fusion site and paralogous segments on other chromosomes. By comparing the sequences of genomic copies and transcripts, we show that at least 18 of the genes in these paralogous regions are transcriptionally active. Among these genes are new members of the cobalamin synthetase W domain (CBWD) and forkhead domain FOXD4 gene families. Copies of RPL23A and SNRPA1 on chromosome 2 are retrotransposed-processed pseudogenes that were included in segmental duplications; we find 53 RPL23A pseudogenes in the human genome and map the functional copy of SNRPA1 to 15qter. The draft sequence of the human genome also provides new information on the location and intron-exon structure of functional copies of other 2q-fusion genes (PGM5, retina-specific F379, helicase CHLR1, and acrosin). This study illustrates that the duplication and rearrangement of subtelomeric and pericentromeric regions have functional relevance to human biology; these processes can change gene dosage and/or generate genes with new functions.
Collapse
MESH Headings
- Amino Acid Sequence/genetics
- Base Sequence/genetics
- Centromere/genetics
- Chromosomes, Human, Pair 2/chemistry
- Chromosomes, Human, Pair 2/physiology
- Cytoskeletal Proteins/genetics
- DNA-Binding Proteins/genetics
- Evolution, Molecular
- Forkhead Transcription Factors
- Gene Duplication
- Genes/genetics
- Humans
- Molecular Sequence Data
- Multigene Family/genetics
- Nitrogenous Group Transferases/genetics
- Organ Specificity/genetics
- Phosphoglucomutase
- Protein Structure, Tertiary/genetics
- Protein Structure, Tertiary/physiology
- Pseudogenes/genetics
- Retina/chemistry
- Retina/metabolism
- Ribonucleoproteins, Small Nuclear/genetics
- Ribosomal Proteins/genetics
- Sequence Homology, Nucleic Acid
- Trans-Activators/genetics
- Translocation, Genetic/genetics
- Translocation, Genetic/physiology
Collapse
Affiliation(s)
- Yuxin Fan
- Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA
| | | | | | | |
Collapse
|
624
|
Crolla JA, van Heyningen V. Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia. Am J Hum Genet 2002; 71:1138-49. [PMID: 12386836 PMCID: PMC385089 DOI: 10.1086/344396] [Citation(s) in RCA: 118] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2002] [Accepted: 08/21/2002] [Indexed: 11/03/2022] Open
Abstract
Seventy-seven patients with aniridia, referred for cytogenetic analysis predominantly to assess Wilms tumor risk, were studied by fluorescence in situ hybridization (FISH), through use of a panel of cosmids encompassing the aniridia-associated PAX6 gene, the Wilms tumor predisposition gene WT1, and flanking markers, in distal chromosome 11p13. Thirty patients were found to be chromosomally abnormal. Cytogenetically visible interstitial deletions involving 11p13 were found in 13 patients, 11 of which included WT1. A further 13 patients had cryptic deletions detectable only by FISH, 3 of which included WT1. Six of these, with deletions <500 kb, share a similar proximal breakpoint within a cosmid containing the last 10 exons of PAX6 and part of the neighboring gene, ELP4. Two of these six patients were mosaic for the deletion. The remaining four had chromosomal rearrangements: an unbalanced translocation, t(11;13), with a deletion including the WAGR (Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation) region, and three balanced rearrangements with what appear to be position effect breakpoints 3' of PAX6: (a) a t(7;11) with the 11p13 breakpoint approximately 30 kb downstream of PAX6, (b) a dir ins(12;11) with a breakpoint >50 kb from PAX6, and (c) an inv(11)(p13q13) with a breakpoint >75 kb downstream of PAX6. The proportion and spectrum of chromosome anomalies in familial (4/14, or 28.5%) and sporadic (26/63, or 41%) cases are not significantly different. An unexpectedly high frequency of chromosomal rearrangements is associated with both sporadic and familial aniridia in this cohort.
Collapse
Affiliation(s)
- John A Crolla
- Wessex Regional Genetics Laboratory, Salisbury District Hospital, United Kingdom.
| | | |
Collapse
|
625
|
Repping S, Skaletsky H, Lange J, Silber S, van der Veen F, Oates RD, Page DC, Rozen S. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 2002; 71:906-22. [PMID: 12297986 PMCID: PMC419997 DOI: 10.1086/342928] [Citation(s) in RCA: 280] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2002] [Accepted: 07/10/2002] [Indexed: 11/04/2022] Open
Abstract
It is widely believed that at least three nonoverlapping regions of the human Y chromosome-AZFa, AZFb, and AZFc ("azoospermia factors" a, b, and c)-are essential for normal spermatogenesis. These intervals are defined by interstitial Y-chromosome deletions that impair or extinguish spermatogenesis. Deletion breakpoints, mechanisms, and lengths, as well as inventories of affected genes, have been elucidated for deletions of AZFa and of AZFc but not for deletions of AZFb or of AZFb plus AZFc. We studied three deletions of AZFb and eight deletions of AZFb plus AZFc, as assayed by the STSs defining these intervals. Guided by Y-chromosome sequence, we localized breakpoints precisely and were able to sequence nine of the deletion junctions. Homologous recombination can explain seven of these deletions but not the remaining two. This fact and our discovery of breakpoint hotspots suggest that factors in addition to homology underlie these deletions. The deletions previously thought to define AZFb were found to extend from palindrome P5 to the proximal arm of palindrome P1, 1.5 Mb within AZFc. Thus, they do not define a genomic region separate from AZFc. We also found that the deletions of AZFb plus AZFc, as assayed by standard STSs heretofore available, in fact extend from P5 to the distal arm of P1 and spare distal AZFc. Both classes of deletions are massive: P5/proximal-P1 deletions encompass up to 6.2 Mb and remove 32 genes and transcripts; P5/distal-P1 deletions encompass up to 7.7 Mb and remove 42 genes and transcripts. To our knowledge, these are the largest of all human interstitial deletions for which deletion junctions and complete intervening sequence are available. The restriction of the associated phenotype to spermatogenic failure indicates the remarkable functional specialization of the affected regions of the Y chromosome.
Collapse
Affiliation(s)
- Sjoerd Repping
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| | - Helen Skaletsky
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| | - Julian Lange
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| | - Sherman Silber
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| | - Fulco van der Veen
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| | - Robert D. Oates
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| | - David C. Page
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| | - Steve Rozen
- Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, Cambridge; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam; Infertility Center of St. Louis, St. Luke’s Hospital, St. Louis; and Department of Urology, Boston University Medical Center, Boston
| |
Collapse
|
626
|
Inoue K, Osaka H, Thurston VC, Clarke JTR, Yoneyama A, Rosenbarker L, Bird TD, Hodes ME, Shaffer LG, Lupski JR. Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 2002; 71:838-53. [PMID: 12297985 PMCID: PMC378540 DOI: 10.1086/342728] [Citation(s) in RCA: 128] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2002] [Accepted: 07/08/2002] [Indexed: 11/03/2022] Open
Abstract
In the majority of patients with Pelizaeus-Merzbacher disease, duplication of the proteolipid protein gene PLP1 is responsible, whereas deletion of PLP1 is infrequent. Genomic mechanisms for these submicroscopic chromosomal rearrangements remain unknown. We identified three families with PLP1 deletions (including one family described elsewhere) that arose by three distinct processes. In one family, PLP1 deletion resulted from a maternal balanced submicroscopic insertional translocation of the entire PLP1 gene to the telomere of chromosome 19. PLP1 on the 19qtel is probably inactive by virtue of a position effect, because a healthy male sibling carries the same der(19) chromosome along with a normal X chromosome. Genomic mapping of the deleted segments revealed that the deletions are smaller than most of the PLP1 duplications and involve only two other genes. We hypothesize that the deletion is infrequent, because only the smaller deletions can avoid causing either infertility or lethality. Analyses of the DNA sequence flanking the deletion breakpoints revealed Alu-Alu recombination in the family with translocation. In the other two families, no homologous sequence flanking the breakpoints was found, but the distal breakpoints were embedded in novel low-copy repeats, suggesting the potential involvement of genome architecture in stimulating these rearrangements. In one family, junction sequences revealed a complex recombination event. Our data suggest that PLP1 deletions are likely caused by nonhomologous end joining.
Collapse
Affiliation(s)
- Ken Inoue
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - Hitoshi Osaka
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - Virginia C. Thurston
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - Joe T. R. Clarke
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - Akira Yoneyama
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - Lisa Rosenbarker
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - Thomas D. Bird
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - M. E. Hodes
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - Lisa G. Shaffer
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| | - James R. Lupski
- Departments of Molecular and Human Genetics and Pediatrics, Baylor College of Medicine, Houston; Department of Degenerative Neurological Diseases and PRESTO, Japan Science and Technology Corporation (JST), National Institute of Neuroscience, NCNP, and Department of Pediatrics, National Rehabilitation Center for Disabled Children, Tokyo; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis; Department of Genetics, The Hospital for Sick Children, Toronto; and Departments of Neurology and Medicine, University of Washington, Seattle
| |
Collapse
|
627
|
Abstract
Human cytogenetics was born in 1956 with the fundamental, but empowering, discovery that normal human cells contain 46 chromosomes. Since then, this field and our understanding of the link between chromosomal defects and disease have grown in spurts that have been fuelled by advances in cytogenetic technology. As a mature enterprise, cytogenetics now informs human genomics, disease and cancer genetics, chromosome evolution and the relationship of nuclear structure to function.
Collapse
Affiliation(s)
- Barbara J Trask
- Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
| |
Collapse
|
628
|
Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, Adams MD, Myers EW, Li PW, Eichler EE. Recent segmental duplications in the human genome. Science 2002; 297:1003-7. [PMID: 12169732 DOI: 10.1126/science.1072047] [Citation(s) in RCA: 979] [Impact Index Per Article: 42.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
Primate-specific segmental duplications are considered important in human disease and evolution. The inability to distinguish between allelic and duplication sequence overlap has hampered their characterization as well as assembly and annotation of our genome. We developed a method whereby each public sequence is analyzed at the clone level for overrepresentation within a whole-genome shotgun sequence. This test has the ability to detect duplications larger than 15 kilobases irrespective of copy number, location, or high sequence similarity. We mapped 169 large regions flanked by highly similar duplications. Twenty-four of these hot spots of genomic instability have been associated with genetic disease. Our analysis indicates a highly nonrandom chromosomal and genic distribution of recent segmental duplications, with a likely role in expanding protein diversity.
Collapse
Affiliation(s)
- Jeffrey A Bailey
- Department of Genetics, Center for Computational Genomics, and Center for Human Genetics, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, OH 44106, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
629
|
Hafezparast M, Ahmad-Annuar A, Wood NW, Tabrizi SJ, Fisher EMC. Mouse models for neurological disease. Lancet Neurol 2002; 1:215-24. [PMID: 12849454 DOI: 10.1016/s1474-4422(02)00100-x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The mouse has many advantages over human beings for the study of genetics, including the unique property that genetic manipulation can be routinely carried out in the mouse genome. Most importantly, mice and human beings share the same mammalian genes, have many similar biochemical pathways, and have the same diseases. In the minority of cases where these features do not apply, we can still often gain new insights into mouse and human biology. In addition to existing mouse models, several major programmes have been set up to generate new mouse models of disease. Alongside these efforts are new initiatives for the clinical, behavioural, and physiological testing of mice. Molecular genetics has had a major influence on our understanding of the causes of neurological disorders in human beings, and much of this has come from work in mice.
Collapse
Affiliation(s)
- Majid Hafezparast
- Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, London, UK
| | | | | | | | | |
Collapse
|
630
|
Paulson HL. Diagnostic testing in neurogenetics. Principles, limitations, and ethical considerations. Neurol Clin 2002; 20:627-43, v. [PMID: 12432824 DOI: 10.1016/s0733-8619(02)00009-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Genetics has emphatically entered the practice of neurology. The last decade witnessed the discovery of the genetic basis of many diseases that primarily affect the nervous system. In areas such as neuromuscular and movement disorders, genetic testing has become a routine part of diagnostic testing. In areas like epilepsy, genetic advances likely will lead to new testing for certain patients. In dementia, the existence of a common predisposing genetic factor (apolipoprotein E) has already raised complex issues such as the appropriateness of genetic testing in specific clinical situations--issues that neurologists will confront more in the future. This article reviews basic principles of genetic testing, its application to neurology, and some limitations and ethical issues confronting the field.
Collapse
Affiliation(s)
- Henry L Paulson
- Department of Neurology, University of Iowa School of Medicine, Iowa City, IA 52242, USA.
| |
Collapse
|
631
|
Giglio S, Calvari V, Gregato G, Gimelli G, Camanini S, Giorda R, Ragusa A, Guerneri S, Selicorni A, Stumm M, Tonnies H, Ventura M, Zollino M, Neri G, Barber J, Wieczorek D, Rocchi M, Zuffardi O. Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation. Am J Hum Genet 2002; 71:276-85. [PMID: 12058347 PMCID: PMC379160 DOI: 10.1086/341610] [Citation(s) in RCA: 149] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2002] [Accepted: 05/02/2002] [Indexed: 11/03/2022] Open
Abstract
The t(4;8)(p16;p23) translocation, in either the balanced form or the unbalanced form, has been reported several times. Taking into consideration the fact that this translocation may be undetected in routine cytogenetics, we find that it may be the most frequent translocation after t(11q;22q), which is the most common reciprocal translocation in humans. Case subjects with der(4) have the Wolf-Hirschhorn syndrome, whereas case subjects with der(8) show a milder spectrum of dysmorphic features. Two pairs of the many olfactory receptor (OR)-gene clusters are located close to each other, on both 4p16 and 8p23. Previously, we demonstrated that an inversion polymorphism of the OR region at 8p23 plays a crucial role in the generation of chromosomal imbalances through unusual meiotic exchanges. These findings prompted us to investigate whether OR-related inversion polymorphisms at 4p16 and 8p23 might also be involved in the origin of the t(4;8)(p16;p23) translocation. In seven case subjects (five of whom both represented de novo cases and were of maternal origin), including individuals with unbalanced and balanced translocations, we demonstrated that the breakpoints fell within the 4p and 8p OR-gene clusters. FISH experiments with appropriate bacterial-artificial-chromosome probes detected heterozygous submicroscopic inversions of both 4p and 8p regions in all the five mothers of the de novo case subjects. Heterozygous inversions on 4p16 and 8p23 were detected in 12.5% and 26% of control subjects, respectively, whereas 2.5% of them were scored as doubly heterozygous. These novel data emphasize the importance of segmental duplications and large-scale genomic polymorphisms in the evolution and pathology of the human genome.
Collapse
Affiliation(s)
- Sabrina Giglio
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Vladimiro Calvari
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Giuliana Gregato
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Giorgio Gimelli
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Silvia Camanini
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Roberto Giorda
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Angela Ragusa
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Silvana Guerneri
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Angelo Selicorni
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Marcus Stumm
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Holger Tonnies
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Mario Ventura
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Marcella Zollino
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Giovanni Neri
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - John Barber
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Dagmar Wieczorek
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Mariano Rocchi
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - Orsetta Zuffardi
- Biologia Generale e Genetica Medica, Università di Pavia, and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Laboratorio di Citogenetica, Istituto Gaslini, Genoa; Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea, Bosisio Parini, Lecco, Italy; Istituto di Ricovero e Cura a Carattere Scientifico Oasi Maria Santissima, Troina, Enna, Italy; Laboratorio di Genetica, Istituti Clinici di Perfezionamento, and Clinica Pediatrica Università di Milano, Milan; Institut fur Humangenetik, Otto-von-Guericke-Universitat, Magdeburg, Germany; Department of Human Genetics, Charite, Campus Virchow, Humboldt-University, Berlin; Dipartimento di Anatomia Patologica e di Genetica, Sezione di Genetica, Bari, Italy; Istituto di Genetica Medica, Universita Cattolica, Rome; Wessex Regional Genetics Laboratory, Salisbury Health Care Trust, Salisbury District Hospital, Salisbury, United Kingdom; and Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| |
Collapse
|
632
|
Saglio G, Storlazzi CT, Giugliano E, Surace C, Anelli L, Rege-Cambrin G, Zagaria A, Jimenez Velasco A, Heiniger A, Scaravaglio P, Torres Gomez A, Roman Gomez J, Archidiacono N, Banfi S, Rocchi M. A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocation. Proc Natl Acad Sci U S A 2002; 99:9882-7. [PMID: 12114534 PMCID: PMC125051 DOI: 10.1073/pnas.152171299] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
A patient with a typical form of chronic myeloid leukemia was found to carry a large deletion on the derivative chromosome 9q+ and an unusual BCR-ABL transcript characterized by the insertion, between BCR exon 14 and ABL exon 2, of 126 bp derived from a region located on chromosome 9, 1.4 Mb 5' to ABL. This sequence was contained in the bacterial artificial chromosome RP11-65J3, which in fluorescence in situ hybridization experiments on normal metaphases was found to detect, in addition to the predicted clear signal at 9q34, a faint but distinct signal at 22q11.2, where the BCR gene is located, suggesting the presence of a large region of homology between the two chromosomal regions. Indeed, blast analysis of the RP11-65J3 sequence against the entire human genome revealed the presence of a stretch of homology, about 76 kb long, located approximately 150 kb 3' to the BCR gene, and containing the 126-bp insertion sequence. Evolutionary studies using fluorescence in situ hybridization identified the region as a duplicon, which transposed from the region orthologous to human 9q34 to chromosome 22 after the divergence of orangutan from the human-chimpanzee-gorilla common ancestor about 14 million years ago. Recent sequence analyses have disclosed an unpredicted extensive segmental duplication of our genome, and the impact of duplicons in triggering genomic disorders is becoming more and more apparent. The discovery of a large duplicon relatively close to the ABL and BCR genes and the finding that the 126-bp insertion is very close to the duplicon at 9q34 open the question of the possible involvement of the duplicon in the formation of the Philadelphia chromosome translocation.
Collapse
MESH Headings
- Animals
- Biological Evolution
- Chromosome Deletion
- Chromosome Mapping
- Chromosomes, Human, Pair 22
- Chromosomes, Human, Pair 9
- Fusion Proteins, bcr-abl/genetics
- Genetic Markers
- Humans
- In Situ Hybridization, Fluorescence
- Karyotyping
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics
- Male
- Middle Aged
- Philadelphia Chromosome
- Primates/genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Translocation, Genetic
Collapse
Affiliation(s)
- Giuseppe Saglio
- Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
633
|
Abstract
The world of molecular diagnostics is undergoing major change because of both technical advances and the availability of rapidly expanding genetic databases generated by the study of human genomics. These resources comprise an extraordinary opportunity to decipher the biological importance of genetic aberrations, and link our understanding with clinical utility. The challenge lies in sorting through the information and developing effective strategies to advance molecular diagnostics.
Collapse
Affiliation(s)
- Stephen Chanock
- Section on Genomic Variation, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
| | | |
Collapse
|
634
|
Abstract
Molecular studies of unstable regions in the human genome have identified region-specific low-copy repeats (LCRs). Unlike highly repetitive sequences (e.g. Alus and LINEs), LCRs are usually of 10-400 kb in size and exhibit > or = 95-97% similarity. According to computer analyses of available sequencing data, LCRs may constitute >5% of the human genome. Through the process of non-allelic homologous recombination using paralogous genomic segments as substrates, LCRs have been shown to facilitate meiotic DNA rearrangements associated with disease traits, referred to as genomic disorders. In addition, this LCR-based complex genome architecture appears to play a major role in both primate karyotype evolution and human tumorigenesis.
Collapse
Affiliation(s)
- Pawel Stankiewicz
- Department of Molecular and Human Genetics, Baylor College of Medicine, Room 604B, One Baylor Plaza, and Texas Children Hospital, Houston, Texas 77030-3498, USA
| | | |
Collapse
|
635
|
Park SS, Stankiewicz P, Bi W, Shaw C, Lehoczky J, Dewar K, Birren B, Lupski JR. Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. Genome Res 2002; 12:729-38. [PMID: 11997339 PMCID: PMC186597 DOI: 10.1101/gr.82802] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
An approximately 4-Mb genomic segment on chromosome 17p11.2, commonly deleted in patients with the Smith-Magenis syndrome (SMS) and duplicated in patients with dup(17)(p11.2p11.2) syndrome, is flanked by large, complex low-copy repeats (LCRs), termed proximal and distal SMS-REP. A third copy, the middle SMS-REP, is located between them. SMS-REPs are believed to mediate nonallelic homologous recombination, resulting in both SMS deletions and reciprocal duplications. To delineate the genomic structure and evolutionary origin of SMS-REPs, we constructed a bacterial artificial chromosome/P1 artificial chromosome contig spanning the entire SMS region, including the SMS-REPs, determined its genomic sequence, and used fluorescence in situ hybridization to study the evolution of SMS-REP in several primate species. Our analysis shows that both the proximal SMS-REP (approximately 256 kb) and the distal copy (approximately 176 kb) are located in the same orientation and derived from a progenitor copy, whereas the middle SMS-REP (approximately 241 kb) is inverted and appears to have been derived from the proximal copy. The SMS-REP LCRs are highly homologous (>98%) and contain at least 14 genes/pseudogenes each. SMS-REPs are not present in mice and were duplicated after the divergence of New World monkeys from pre-monkeys approximately 40-65 million years ago. Our findings potentially explain why the vast majority of SMS deletions and dup(17)(p11.2p11.2) occur at proximal and distal SMS-REPs and further support previous observations that higher-order genomic architecture involving LCRs arose recently during primate speciation and may predispose the human genome to both meiotic and mitotic rearrangements.
Collapse
MESH Headings
- Abnormalities, Multiple/genetics
- Base Composition/genetics
- Cell Line
- Cell Line, Transformed
- Chromosomes, Human, Pair 17/genetics
- Cloning, Molecular/methods
- Contig Mapping/methods
- DNA Fingerprinting/methods
- Evolution, Molecular
- Gene Dosage
- Gene Duplication
- Genome, Human
- Humans
- Intellectual Disability/genetics
- Multigene Family/genetics
- Repetitive Sequences, Nucleic Acid/genetics
- Sequence Alignment/methods
- Sequence Analysis, DNA/methods
- Sequence Homology, Nucleic Acid
- Syndrome
Collapse
Affiliation(s)
- Sung-Sup Park
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 77030, USA
| | | | | | | | | | | | | | | |
Collapse
|
636
|
Eichler EE, DeJong PJ. Biomedical applications and studies of molecular evolution: a proposal for a primate genomic library resource. Genome Res 2002; 12:673-8. [PMID: 11997334 DOI: 10.1101/gr.250102] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
The anticipated completion of two of the most biomedically relevant genomes, mouse and human, within the next three years provides an unparalleled opportunity for the large-scale exploration of genome evolution. Targeted sequencing of genomic regions in a panel of primate species and comparison to reference genomes will provide critical insight into the nature of single-base pair variation, mechanisms of chromosomal rearrangement, patterns of selection, and species adaptation. Although not recognized as model "genetic organisms" because of their longevity and low fecundity, 30 of the approximately 300 primate species are targets of biomedical research. The existence of a human reference sequence and genomic primate BAC libraries greatly facilitates the recovery of genes/genomic regions of high biological interest because of an estimated maximum neutral nucleotide sequence divergence of 25%. Primate species, therefore, may be regarded as the ideal model "genomic organisms". Based on existing BAC library resources, we propose the construction of a panel of primate BAC libraries from phylogenetic anchor species for the purpose of comparative medicine as well as studies of genome evolution.
Collapse
Affiliation(s)
- Evan E Eichler
- Department of Genetics, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio 44106, USA.
| | | |
Collapse
|
637
|
Bi W, Yan J, Stankiewicz P, Park SS, Walz K, Boerkoel CF, Potocki L, Shaffer LG, Devriendt K, Nowaczyk MJM, Inoue K, Lupski JR. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse. Genome Res 2002; 12:713-28. [PMID: 11997338 PMCID: PMC186594 DOI: 10.1101/gr.73702] [Citation(s) in RCA: 86] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Smith-Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome associated with behavioral abnormalities and sleep disturbance. Most patients have the same approximately 4 Mb interstitial genomic deletion within chromosome 17p11.2. To investigate the molecular bases of the SMS phenotype, we constructed BAC/PAC contigs covering the SMS common deletion interval and its syntenic region on mouse chromosome 11. Comparative genome analysis reveals the absence of all three approximately 200-kb SMS-REP low-copy repeats in the mouse and indicates that the evolution of SMS-REPs was accompanied by transposition of adjacent genes. Physical and genetic map comparisons in humans reveal reduced recombination in both sexes. Moreover, by examining the deleted regions in SMS patients with unusual-sized deletions, we refined the minimal Smith-Magenis critical region (SMCR) to an approximately 1.1-Mb genomic interval that is syntenic to an approxiamtely 1.0-Mb region in the mouse. Genes within the SMCR and its mouse syntenic region were identified by homology searches and by gene prediction programs, and their gene structures and expression profiles were characterized. In addition to 12 genes previously mapped, we identified 8 new genes and 10 predicted genes in the SMCR. In the mouse syntenic region of the human SMCR, 16 genes and 6 predicted genes were identified. The SMCR is highly conserved between humans and mice, including 19 genes with the same gene order and orientation. Our findings will facilitate both the identification of gene(s) responsible for the SMS phenotype and the engineering of an SMS mouse model.
Collapse
Affiliation(s)
- Weimin Bi
- Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|